PROM1 and cancer: In addition, we have shown that that the TPGS-FA/NC treatment markedly reduced the positive EpCAM/CD133 cell fraction as examined by FACS analysis, which suggested to be related with a suppressed self-renewal capability of these cancer stem-like cells.